Research Summary
Pulmonary drug delivery systems are medical devices designed to administer medications directly to the lungs through inhalation. These systems are commonly used for the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, among others. The main goal of pulmonary drug delivery is to target the medication to the respiratory system, providing rapid onset of action and minimizing systemic side effects. Inhalation devices include pressurized metered-dose inhalers (pMDIs), dry powder inhalers (DPIs), and nebulizers, each delivering medication in a specific form (aerosolized particles or dry powder). Pulmonary drug delivery systems are preferred for certain medications as they allow for direct absorption into the bloodstream through the lungs, offering an effective and convenient route for delivering bronchodilators, corticosteroids, and other respiratory medications.
According to DIResearch's in-depth investigation and research, the global Pulmonary Drug Delivery Systems market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Pulmonary Drug Delivery Systems include 3M, GSK, AstraZeneca, Cipla, Chiesi, Aptar, Boehringer Ingelheim, Novartis, Omron Healthcare, Philips Respironics, PARI, Skyepharma, CareFusion, Shanghai Huarui, Taian Character, Chia Tai Tianqing etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Pulmonary Drug Delivery Systems. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pulmonary Drug Delivery Systems market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pulmonary Drug Delivery Systems market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pulmonary Drug Delivery Systems industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy. ? ?
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Pulmonary Drug Delivery Systems Include:
3M
GSK
AstraZeneca
Cipla
Chiesi
Aptar
Boehringer Ingelheim
Novartis
Omron Healthcare
Philips Respironics
PARI
Skyepharma
CareFusion
Shanghai Huarui
Taian Character
Chia Tai Tianqing
Pulmonary Drug Delivery Systems Product Segment Include:
Nebulizers
Dry Powder Inhaler (DPI)
Metered Dose Inhaler (MDI)
Pulmonary Drug Delivery Systems Product Application Include:
COPD
Asthma
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Pulmonary Drug Delivery Systems Industry PESTEL Analysis
Chapter 3: Global Pulmonary Drug Delivery Systems Industry Porter's Five Forces Analysis
Chapter 4: Global Pulmonary Drug Delivery Systems Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Pulmonary Drug Delivery Systems Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Pulmonary Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Pulmonary Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Pulmonary Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Pulmonary Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Pulmonary Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Pulmonary Drug Delivery Systems Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Pulmonary Drug Delivery Systems Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Pulmonary Drug Delivery Systems Market Overview 1.1 Product Definition and Statistical Scope 1.2 Pulmonary Drug Delivery Systems Product by Type 1.2.1 Global Pulmonary Drug Delivery Systems Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Nebulizers 1.2.3 Dry Powder Inhaler (DPI) 1.2.4 Metered Dose Inhaler (MDI) 1.3 Pulmonary Drug Delivery Systems Product by Application 1.3.1 Global Pulmonary Drug Delivery Systems Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 COPD 1.3.3 Asthma 1.3.4 Others 1.4 Global Pulmonary Drug Delivery Systems Market Revenue and Sales Analysis 1.4.1 Global Pulmonary Drug Delivery Systems Market Size Analysis (2019-2030) 1.4.2 Global Pulmonary Drug Delivery Systems Market Sales Analysis (2019-2030) 1.4.3 Global Pulmonary Drug Delivery Systems Market Sales Price Trend Analysis (2019-2030) 1.5 Pulmonary Drug Delivery Systems Market Development Status and Trends 1.5.1 Pulmonary Drug Delivery Systems Industry Development Status Analysis 1.5.2 Pulmonary Drug Delivery Systems Industry Development Trends Analysis 2 Pulmonary Drug Delivery Systems Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Pulmonary Drug Delivery Systems Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Pulmonary Drug Delivery Systems Market Analysis by Regions 4.1 Pulmonary Drug Delivery Systems Overall Market: 2023 VS 2024 VS 2030 4.2 Global Pulmonary Drug Delivery Systems Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Pulmonary Drug Delivery Systems Revenue and Market Share by Region (2019-2024) 4.2.2 Global Pulmonary Drug Delivery Systems Revenue Forecast by Region (2025-2030) 4.3 Global Pulmonary Drug Delivery Systems Sales and Forecast Analysis (2019-2030) 4.3.1 Global Pulmonary Drug Delivery Systems Sales and Market Share by Region (2019-2024) 4.3.2 Global Pulmonary Drug Delivery Systems Sales Forecast by Region (2025-2030) 4.4 Global Pulmonary Drug Delivery Systems Sales Price Trend Analysis (2019-2030) 5 Global Pulmonary Drug Delivery Systems Market Size by Type and Application 5.1 Global Pulmonary Drug Delivery Systems Market Size by Type 5.1.1 Global Pulmonary Drug Delivery Systems Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global Pulmonary Drug Delivery Systems Sales and Forecast Analysis by Type (2019-2030) 5.2 Global Pulmonary Drug Delivery Systems Market Size by Application 5.2.1 Global Pulmonary Drug Delivery Systems Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global Pulmonary Drug Delivery Systems Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America Pulmonary Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Pulmonary Drug Delivery Systems Market Size by Type 6.3.1 North America Pulmonary Drug Delivery Systems Sales by Type (2019-2030) 6.3.2 North America Pulmonary Drug Delivery Systems Revenue by Type (2019-2030) 6.4 North America Pulmonary Drug Delivery Systems Market Size by Application 6.4.1 North America Pulmonary Drug Delivery Systems Sales by Application (2019-2030) 6.4.2 North America Pulmonary Drug Delivery Systems Revenue by Application (2019-2030) 6.5 North America Pulmonary Drug Delivery Systems Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Pulmonary Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Pulmonary Drug Delivery Systems Market Size by Type 7.3.1 Europe Pulmonary Drug Delivery Systems Sales by Type (2019-2030) 7.3.2 Europe Pulmonary Drug Delivery Systems Revenue by Type (2019-2030) 7.4 Europe Pulmonary Drug Delivery Systems Market Size by Application 7.4.1 Europe Pulmonary Drug Delivery Systems Sales by Application (2019-2030) 7.4.2 ? Europe Pulmonary Drug Delivery Systems Revenue by Application (2019-2030) 7.5 Europe Pulmonary Drug Delivery Systems Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Pulmonary Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Pulmonary Drug Delivery Systems Market Size by Type 8.3.1 China Pulmonary Drug Delivery Systems Sales by Type (2019-2030) 8.3.2 China Pulmonary Drug Delivery Systems Revenue by Type (2019-2030) 8.4 China Pulmonary Drug Delivery Systems Market Size by Application 8.4.1 China Pulmonary Drug Delivery Systems Sales by Application (2019-2030) 8.4.2 China Pulmonary Drug Delivery Systems Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) Pulmonary Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Pulmonary Drug Delivery Systems Market Size by Type 9.3.1 APAC (excl. China) Pulmonary Drug Delivery Systems Sales by Type (2019-2030) 9.3.2 APAC (excl. China) Pulmonary Drug Delivery Systems Revenue by Type (2019-2030) 9.4 APAC (excl. China) Pulmonary Drug Delivery Systems Market Size by Application 9.4.1 APAC (excl. China) Pulmonary Drug Delivery Systems Sales by Application (2019-2030) 9.4.2 APAC (excl. China) Pulmonary Drug Delivery Systems Revenue by Application (2019-2030) 9.5 APAC (excl. China) Pulmonary Drug Delivery Systems Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Pulmonary Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Pulmonary Drug Delivery Systems Market Size by Type 10.3.1 Latin America Pulmonary Drug Delivery Systems Sales by Type (2019-2030) 10.3.2 Latin America Pulmonary Drug Delivery Systems Revenue by Type (2019-2030) 10.4 Latin America Pulmonary Drug Delivery Systems Market Size by Application 10.4.1 Latin America Pulmonary Drug Delivery Systems Sales by Application (2019-2030) 10.4.2 Latin America Pulmonary Drug Delivery Systems Revenue by Application (2019-2030) 10.5 Latin America Pulmonary Drug Delivery Systems Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Pulmonary Drug Delivery Systems Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Pulmonary Drug Delivery Systems Market Size by Type 11.3.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Type (2019-2030) 11.3.2 Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Type (2019-2030) 11.4 Middle East & Africa Pulmonary Drug Delivery Systems Market Size by Application 11.4.1 Middle East & Africa Pulmonary Drug Delivery Systems Sales by Application (2019-2030) 11.4.2 Middle East & Africa Pulmonary Drug Delivery Systems Revenue by Application (2019-2030) 11.5 Middle East & Africa Pulmonary Drug Delivery Systems Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global Pulmonary Drug Delivery Systems Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global Pulmonary Drug Delivery Systems Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global Pulmonary Drug Delivery Systems Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global Pulmonary Drug Delivery Systems Average Sales Price by Manufacturers (2020-2024) 12.2 Pulmonary Drug Delivery Systems Competitive Landscape Analysis and Market Dynamic 12.2.1 Pulmonary Drug Delivery Systems Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 3M 13.1.1 3M Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 3M Pulmonary Drug Delivery Systems Product Portfolio 13.1.3 3M Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 GSK 13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 GSK Pulmonary Drug Delivery Systems Product Portfolio 13.2.3 GSK Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 AstraZeneca 13.3.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 AstraZeneca Pulmonary Drug Delivery Systems Product Portfolio 13.3.3 AstraZeneca Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Cipla 13.4.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Cipla Pulmonary Drug Delivery Systems Product Portfolio 13.4.3 Cipla Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Chiesi 13.5.1 Chiesi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Chiesi Pulmonary Drug Delivery Systems Product Portfolio 13.5.3 Chiesi Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Aptar 13.6.1 Aptar Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Aptar Pulmonary Drug Delivery Systems Product Portfolio 13.6.3 Aptar Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 Boehringer Ingelheim 13.7.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Boehringer Ingelheim Pulmonary Drug Delivery Systems Product Portfolio 13.7.3 Boehringer Ingelheim Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Novartis 13.8.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Novartis Pulmonary Drug Delivery Systems Product Portfolio 13.8.3 Novartis Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Omron Healthcare 13.9.1 Omron Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Omron Healthcare Pulmonary Drug Delivery Systems Product Portfolio 13.9.3 Omron Healthcare Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 Philips Respironics 13.10.1 Philips Respironics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Philips Respironics Pulmonary Drug Delivery Systems Product Portfolio 13.10.3 Philips Respironics Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 PARI 13.11.1 PARI Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 PARI Pulmonary Drug Delivery Systems Product Portfolio 13.11.3 PARI Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 Skyepharma 13.12.1 Skyepharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Skyepharma Pulmonary Drug Delivery Systems Product Portfolio 13.12.3 Skyepharma Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.13 CareFusion 13.13.1 CareFusion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 CareFusion Pulmonary Drug Delivery Systems Product Portfolio 13.13.3 CareFusion Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.14 Shanghai Huarui 13.14.1 Shanghai Huarui Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Shanghai Huarui Pulmonary Drug Delivery Systems Product Portfolio 13.14.3 Shanghai Huarui Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.15 Taian Character 13.15.1 Taian Character Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Taian Character Pulmonary Drug Delivery Systems Product Portfolio 13.15.3 Taian Character Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.16 Chia Tai Tianqing 13.16.1 Chia Tai Tianqing Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Chia Tai Tianqing Pulmonary Drug Delivery Systems Product Portfolio 13.16.3 Chia Tai Tianqing Pulmonary Drug Delivery Systems Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Pulmonary Drug Delivery Systems Industry Chain Analysis 14.2 Pulmonary Drug Delivery Systems Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Pulmonary Drug Delivery Systems Typical Downstream Customers 14.4 Pulmonary Drug Delivery Systems Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024
- Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024
- Global Orthopaedics Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support